ClinicalTrials.Veeva

Menu

USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC (LLM-ILD)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Not yet enrolling

Conditions

Interstitial Disease

Treatments

Other: Survey

Study type

Interventional

Funder types

Other

Identifiers

NCT06852794
7002 (Other Identifier)

Details and patient eligibility

About

The present study aims to evaluate the usefulness of artificial intelligence (AI) in the back-office of an ILD (Interstitial Lung Disease) clinic.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients attending ILD clinic of the IRCCS Fondazione Policlinico A. Gemelli.

Exclusion criteria

  • Patients unable or unwilling to sign the informed consent
  • Patients who are senders of one of the emails chosen for the questionnaire
  • Patients with manifest inability to fill out the questionnaire

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Patients attending ILD clinic
Experimental group
Treatment:
Other: Survey

Trial contacts and locations

0

Loading...

Central trial contact

Diana Verdirosi, Sc; Luca Richeldi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems